Insights

Reimagining the future

Life Science

UTI Diagnostics: An opportunity to improve antimicrobial stewardship and women’s health

Life Science

Do you trust your software? Why you should seriously consider using Rust in your next diagnostic and medical device

Life Science

Plug and play genomics for next-gen therapies

Life Science

Distributing diagnostics: locations, motivations, metrics

Cell and Gene Therapy

Non-contact cell counting enables in-line, real-time monitoring of manufacturing processes 

Cell and Gene Therapy

Treatment of chronic conditions is the new frontier for stem cell-derived therapies: Deep phenotyping and manufacturing scale-up key to opening clinic doors, say experts at TTP’s panel discussion 

Life Science

In the Hot Seat: Challenging Conventions in Precision Medicine

mrna personalised cancer vaccine cell render
Life Science

Personalised mRNA therapies are coming and will challenge established analytical technologies: Should we look to the diagnostics sector for improved Quality Control? 

using omics to quality control cell and gene therapy
Life Science

Omics: Unlocking a New Era of Quality Control and Treatment Insight for Cell and Gene Therapy

Life Science

A Greener Future of Discovery with More Powerful Drug Screens

cancer cells being attacked by T Cells
Cell and Gene Therapy

With personalised cancer vaccines on the rise, is manufacturing scalable yet?

Protein DNA
Life Science

Multi-omics: When Worlds Collide, Opportunities Arise

diagnostic test
Life Science

Seven ideas to reduce the environmental impact of point-of-care diagnostics

Life Science

A new era in point-of-care diagnostic testing: possibilities and practicalities

woman in lab carrying out library prep
Life Science

Shape Up, Library Prep: Innovating for Efficient, Low Cost and Sustainable Workflows

eDNA with a city background
Life Science

Environmental DNA and RNA: versatile tools with huge untapped commercial potential

Life Science

Diagnostics: areas of growth, change, and wider interest that could transform the industry

Life Science

How is cell and gene therapy innovation adapting to a changing investment landscape? Insights from TTP’s Cell & Gene panel event

Life Science

Are we entering a new era in point-of-care diagnostic testing?

Life Science

How can you prove 99.9% reliability? A challenge in automating and scaling cell therapies

Life Science

Spatial biology: FISH and sequencing reveal gene expression patterns. Where is the industry now, and what will the future bring?

Life Science

Translating spatial biology into tissue diagnostics with inventive technology

Life Science

Next-generation sample preparation: Will better nucleic acid extraction unleash biotechnology, life sciences and diagnostics?

Life Science

As we predicted: Isothermal amplification diagnostics shoot to prominence in point-of-care market

up close of a chip for manufacturing
Life Science

Could the “chip shortage” hit your product? Here’s what to do.

Life Science

Multiplex cytokine measurement: Covid and beyond

Life Science

The antimicrobial susceptibility testing conundrum

Life Science

Front-loading monoclonal antibody screening for faster drug discovery

Life Science

What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development

Life Science

Biomimetics evolution at the micron scale and beyond

Life Science

Special Delivery: can advanced intracellular delivery enable superior cell therapies for solid tumour treatment – and beyond?

Life Science

Only a ‘click’ away: click chemistry transforms life science applications

Life Science

DNA Origami: What can we make of it?

Life Science

Key early-stage microfabrication decisions for life science start-ups and SMEs

Life Science

Spotlight on upconversion nanoparticles: finding the right chemistry to make life science applications “click”

Life Science

Imaging by the numbers: quantitative imaging for digital pathology

There are no insights for your current selection. Please select a different industry.